Literature DB >> 26993490

Clinical guide SEOM: hepatocellular carcinoma (HCC): considerations on SBRT.

F Arias1, G Asín2, A Viúdez2.   

Abstract

Entities:  

Year:  2016        PMID： 26993490     DOI： 10.1007/s12094-016-1501-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  5 in total

Review 1.  Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice.

Authors:  Robert D Timmerman; Joseph Herman; L Chinsoo Cho
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

2.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.

Authors:  Alexis Bujold; Christine A Massey; John J Kim; James Brierley; Charles Cho; Rebecca K S Wong; Rob E Dinniwell; Zahra Kassam; Jolie Ringash; Bernard Cummings; Jenna Sykes; Morris Sherman; Jennifer J Knox; Laura A Dawson
Journal:  J Clin Oncol       Date:  2013-04-01       Impact factor: 44.544

3.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Daniel R Wahl; Matthew H Stenmark; Yebin Tao; Erqi L Pollom; Elaine M Caoili; Theodore S Lawrence; Matthew J Schipper; Mary Feng
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

4.  Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.

Authors:  Vincenzo Mazzaferro; Carlo Battiston; Stefano Perrone; Andrea Pulvirenti; Enrico Regalia; Raffaele Romito; Dario Sarli; Marcello Schiavo; Francesco Garbagnati; Alfonso Marchianò; Carlo Spreafico; Tiziana Camerini; Luigi Mariani; Rosalba Miceli; Salvatore Andreola
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

5.  Clinical guideline SEOM: hepatocellular carcinoma.

Authors:  J Sastre; R Díaz-Beveridge; J García-Foncillas; R Guardeño; C López; R Pazo; N Rodriguez-Salas; M Salgado; A Salud; J Feliu
Journal:  Clin Transl Oncol       Date:  2015-11-25       Impact factor: 3.405
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.